The Mechanisms of Immune Evasion in Cancer Stem Cells and Related Immunotherapy Advances
DOI:
https://doi.org/10.62051/5jdc5d80Keywords:
Cancer Stem Cells, Immune Evasion Mechanisms, Immune Checkpoints, CAR-T Cell TherapyAbstract
Cancer Stem Cells (CSCs), as a unique subset of tumor cells, play a crucial role in tumor initiation, progression, and recurrence due to their self-renewal and differentiation capabilities. CSCs exhibit significant immune evasion abilities, allowing them to escape host immune surveillance, leading to the failure of conventional treatments. This paper reviews the definition, characteristics, and immune evasion mechanisms of CSCs, including immune checkpoint pathways, immunosuppressive microenvironment, and changes in surface antigen expression. Additionally, it explores various immunotherapies targeting CSCs, such as immune checkpoint inhibitors, CAR-T cell therapy, tumor vaccines, and other emerging therapies, discussing their research progress and clinical application prospects. By comprehensively understanding the immune evasion mechanisms of CSCs and related immunotherapies, we aim to provide new insights and strategies for future cancer treatments.
Downloads
References
[1] Tsuchiya, Hiroyuki, and Goshi Shiota. "Immune evasion by cancer stem cells." Regenerative Therapy 17 (2021): 20-33.
[2] Jin, Ming Li, and Kwang Won Jeong. "Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective." Experimental & Molecular Medicine 55.7 (2023): 1333-1347.
[3] Dianat-Moghadam, Hassan, et al. "Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy." Stem Cell Research & Therapy 13.1 (2022): 150-151.
[4] Su, Rui, et al. "Targeting FTO suppresses cancer stem cell maintenance and immune evasion." Cancer cell 38.1 (2020): 79-96.
[5] Dai, Xiaomeng, et al. "Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma." Theranostics 11.7 (2021): 3489-3450.
[6] Chakraborty, Sourio, et al. "Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy." Exploration of Immunology 3.4 (2023): 384-405.
[7] Wang, Cheng, et al. "CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance." Cell stem cell 28.9 (2021): 1597-1613.
[8] Wu, Bo, et al. "Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment." Molecular Cancer 22.1 (2023): 38-42.
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







